Thursday, January 21, 2021
Tags Chinese pharmaceuticals

Tag: Chinese pharmaceuticals

State Media Says China’s New Patent Law Could Reduce Pharmaceutical Release Time

China's state media reports that upcoming amendments to the country's patent law are likely to reduce the time it takes pharmaceuticals to reach the...

China Cancels Tariff on Imported Anti-Cancer Drugs

The Chinese government has officially cancelled tariffs on imported anti-cancer drugs as of 1 May 2018. China's National Health Commission announced the launch of a...

Most Read

Users of Everbright’s Cloud-Driven Utilities Payment Platform Exceeded Half a Billion in 2020

China Everbright Bank has seen users of its cloud-based utilities payments service surge in 2020, as the COVID-19 pandemic drove sharp gains...

China Unlikely to See Real Estate Loan Rates Decline in 2021 as LPR Holds Steady for Ninth Month Straight

Domestic analysts say that Chinese banks are unlikely to significantly reduce rates for real estate loans in 2021, as regulators continue to...

Chinese Central Bank Unveils Anti-Trust Measures Permitting Break up of Third-Party Payments Platforms

The People's Bank of China (PBOC) will have the power to recommend the dismantling of third party payments platforms under new measures...

Pinduoduo Owner Applies for Payments Trademark

A major shareholder in NASDAQ-listed agricommerce platform Pinduoduo has applied with Chinese authorities to register a Pinduoduo-related payments trademark.